Journal of Surgery Concepts & Practice ›› 2021, Vol. 26 ›› Issue (02): 163-166.doi: 10.16139/j.1007-9610.2021.02.014

• Original article • Previous Articles     Next Articles

Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of pancreaticobiliary maljunction

ZHOU Haibin1, JIN Hangbin2, HUANG Haitao2, YANG Jing2, LÜ Wen2, ZHANG Xiaofeng2, YANG Jianfeng2()   

  1. 1. Department of Gastroenterology, Affiliated Hangzhou First People's Hospital (North Campus), Zhejiang University School of Medicine, Zhejiang Hangzhou 310022, China
    2. Department of Gastroenterology Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Zhejiang Hangzhou 310006, China
  • Received:2020-09-30 Online:2021-03-25 Published:2022-07-27
  • Contact: YANG Jianfeng E-mail:yjf3303@zju.edu.cn

Abstract:

Objective To investigate the effect and safety of endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis and treatment of pancreaticobiliary maljunction (PBM). Methods The patients with PBM were diagnosed and treated using ERCP and included from December 2007 to August 2020 in Hangzhou First People's Hospital of Zhejiang University School of Medicine. The clinical manifestations of PBM, ERCP treatment, and post ERCP complications were analyzed. Results A total of 219 patients with PBM were in this study including 95 males and 124 females with an average age of (52.11±23.32) (2-89) years. Abdominal pain (77.93%) was the main clinical manifestations of PBM. The success rate of endoscopy intubation was 98.17% (215/219), and the cases with curative ERCP was 96.80% (212/219). Twenty-three of ERCP(7.93%) had post ERCP complications cured all by conservative treatment. Conclusions PBM is more common in women with main manifestation of abdominal pain. ERCP is effective and safe for biliary and pancreatic diseases induced by PBM.

Key words: Endoscopic retrograde cholangiopancreatography, Pancreaticobiliary maljunction, Acute pancreatitis

CLC Number: